Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2022-01-21 2022-01-17
Drug Identification Number 02139480 02139480
Brand name FOLIC ACID INJECTION, USP FOLIC ACID INJECTION, USP
Common or Proper name FOLIC ACID INJECTION FOLIC ACID INJECTION
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients FOLIC ACID FOLIC ACID
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 1 1
ATC code B03BB B03BB
ATC description VITAMIN B12 AND FOLIC ACID VITAMIN B12 AND FOLIC ACID
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-01-14 2022-01-14
Actual start date 2022-01-14 2022-01-14
Estimated end date 2022-01-20 2022-01-20
Actual end date 2022-01-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Folic Acid for Injection 5mg/mL Vial 10mL effective today, January 14, 2022 until January 20, 2022. Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Folic Acid for Injection 5mg/mL Vial 10mL effective today, January 14, 2022 until January 20, 2022.
Health Canada comments